Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2008 Jun 28;10(5):290–295. doi: 10.1111/j.1939-1676.1996.tb02064.x

Vaccine‐Associated Immune‐Mediated Hemolytic Anemia in the Dog

Derek Duval 1, Urs Giger 1,✉
PMCID: PMC7166356  PMID: 8884713

Abstract

Vaccination has been incriminated as a trigger of immune‐mediated hemolytic anemia (IMHA) in dogs and in people, but evidence to support this association is lacking. In a controlled retrospective study, idiopathic IMHA was identified in 58 dogs over a 27–month period. When compared with a randomly selected control group of 70 dogs (presented for reasons other than IMHA) over the same period, the distribution of cases versus time since vaccination was different (P < .05). Fifteen of the dogs (26%) had been vaccinated within 1 month (mean, 13 days; median, 14 days; range, 1 to 27 days) of developing IMHA (P < .0001), whereas in the control group no marked increase in frequency of presentation was seen in the first month after vaccination. The dogs with IMHA were divided into 2 groups based on time since vaccination: the vaccine IMHA group included dogs vaccinated within 1 month of developing IMHA; the nonvaccine IMHA group included dogs that developed IMHA more than 1 month after vaccination. The recently vaccinated dogs with IMHA (vaccine IMHA group) had significantly lower platelet counts (P < .05) and a trend towards increased prevalence of intravascular hemolysis and autoagglutination when compared with the nonvaccine IMHA group. Similar mortality rates were seen in the vaccine IMHA group (60%) and the nonvaccine IMHA group (44%), with the majority of fatalities (>75%) occurring in the first 3 weeks after presentation. Persistent autoagglutination was a negative prognostic indicator for survival in both groups (P < .05). Presence of icterus and hyperbilirubinemia were negative prognostic indicators for survival in the nonvaccine IMHA group (P < .0001 and P < .01, respectively) but not in the vaccine IMHA group. In the recently vaccinated dogs, combination vaccines from various manufacturers against canine distemper, adenovirus type 2, leptospirosis, parainfluenza, and parvovirus (DHLPP) were involved in each case. Vaccines against rabies virus, Bordetella spp, coronavirus, and Lyme Borrelia were administered concomitantly to some dogs. This study provides the first clinical evidence for a temporal relationship of vaccine‐associated IMHA in the dog.

References

  • 1. Klag AR, Giger U., Shofer FS. Idiopathic immune‐mediated hemolytic anemia in dogs: 42 cases (1986–1990). J Am Vet Med Assoc 1993;202:783–788. [PubMed] [Google Scholar]
  • 2. Dodds WJ. Immune‐mediated diseases of the blood. Adv Vet Sci Comp Med 1983;27:163–196. [PubMed] [Google Scholar]
  • 3. Stockham SL, Ford RB, Weiss DJ. Canine autoimmune hemolytic disease with a delayed erythroid regeneration. J Am Anim Hosp Assoc 1980; 16:927–931. [Google Scholar]
  • 4. Dodds WJ. Contributions and future directions of hemostasis research. J Am Vet Med Assoc 1988; 193:1157–1160. [PubMed] [Google Scholar]
  • 5. Werner LL. Coombs' positive anemias in the dog and cat. Compend Cont Ed Pract Vet 1980; 2:96–102. [Google Scholar]
  • 6. Dodds WJ. Immune‐mediated blood diseases in Dogs. Part 1‐Signs and diagnosis. Mod Vet Pract 1983 May:375–379.
  • 7. Jackson ML, Kruth SA. Immune‐mediated hemolytic anemia and thrombocytopenia in the dog: A retrospective study of 55 cases diagnosed from 1969 through 1983 at the Western College of Veterinary Medicine. Can Vet J 1985;26:245–250. [PMC free article] [PubMed] [Google Scholar]
  • 8. Jacobs RM, Murtaugh RJ, Crocker DB. Use of a microtiter Coombs' test for study on age, gender, and breed distributions in immunohemolytic anemia of the dog. J Am Vet Med Assoc 1984; 185:66–69. [PubMed] [Google Scholar]
  • 9. Schalm OW. Autoimmune hemolytic anemia in the dog. Canine Pract 1975;2:37–45. [Google Scholar]
  • 10. Switzer JW, Jain NC. Autoimmune hemolytic anemia in dogs and cats. Vet Clin North Am Small Anim Pract 1981; 11:405–420. [DOI] [PubMed] [Google Scholar]
  • 11. Feller W. An introduction to probability theory and applications. New York , NY : Wiley; 1950:54. [Google Scholar]
  • 12. Haneberg B., Matre R., Winsnes R., et al. Acute hemolytic anemia related to diphtheria‐pertussis‐tetanus vaccination. Acta Pae-diatr Scand 1978;67:345–350. [DOI] [PubMed] [Google Scholar]
  • 13. Howson CP, Fineberg HV. Adverse events following pertussis and rubella vaccines. J Am Med Assoc 1992;267:392–396. [PubMed] [Google Scholar]
  • 14. Greene CE. Immunoprophylaxis and immunotherapy In: Green CE, ed. Infectious Diseases of the Dog and Cat. Philadelphia , PA : WB Saunders; 1990:21–54. [Google Scholar]
  • 15. Hendrick, MJ , Dunagan CA. Focal necrotizing granulomatous panniculitis associated with subcutaneous injection of rabies vaccine in cats and dogs: 10 cases (1988–1989). J Am Vet Med Assoc 1991; 198:304–305. [PubMed] [Google Scholar]
  • 16. Tizard I. Veterinary Immunology—An Introduction, 3rd ed. Philadelphia , PA : WB Saunders; 1987:381. [Google Scholar]
  • 17. Kass PH, Barnes WG, Spangler WL, et al. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med Assoc 1993;203:396–405. [PubMed] [Google Scholar]
  • 18. Hendrick MJ, Goldschmidt MH, Shofer FS, et al. Postvaccination sarcomas in the cat: Epidemiology and electron probe micro‐analytical identification of aluminum. Cancer Res 1992;52:5391–5394. [PubMed] [Google Scholar]
  • 19. Hendrick MJ, Shofer FS, Goldschmidt MH, et al. Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991–1992). J Am Vet Med Assoc 1994;205:1425–1429. [PubMed] [Google Scholar]
  • 20. Pineau A., Durand C., Guillard O., et al. Role of aluminium in skin reactions after diptheria‐tetanus‐pertussis‐poliomyelitis vaccination: An experimental study in rabbits. Toxicology 1992; 73:117–125. [DOI] [PubMed] [Google Scholar]
  • 21. Fine PE. Methodological issues in the evaluation and monitoring of vaccine safety In Williams JC, Goldenthal KL, Bums DL, et al, eds. Combined Vaccines and Simultaneous Administration. Current Issues and Perspectives. New York , NY : New York Academy of Sciences; 1995:300–308. [DOI] [PubMed] [Google Scholar]
  • 22. Azeemuddin S. Thrombocytopenia purpura after combined vaccine against measles, mumps, and rubella. Clin Pediatr 1987;26:318. [DOI] [PubMed] [Google Scholar]
  • 23. Citron ML, Moss BM. Pneumococcal‐vaccine‐induced thrombocytopenia. J Am Med Assoc 1982;248:1178. [DOI] [PubMed] [Google Scholar]
  • 24. Kelton JG. Vaccination‐associated relapse of immune thrombocytopenia. J Am Med Assoc 1981;245:369–371. [PubMed] [Google Scholar]
  • 25. Neiderud J. Thrombocytopenic purpura after a combined vaccine against morbilli, parotitis and rubella. Acta Paediatr Scand 1983; 72:613–614. [DOI] [PubMed] [Google Scholar]
  • 26. McAnulty JF, Rudd, RG. Thrombocytopenia associated with vaccination of a dog with a modified‐live paramyxovirus vaccine. J Am Vet Med Assoc. 1985; 186:1217–1219. [PubMed] [Google Scholar]
  • 27. Pineau S., Belbeck LW, Moore S. Levamisole reduces the thrombocytopenia associated with myxovirus vaccination. Can Vet J 1980;21:82–84. [PMC free article] [PubMed] [Google Scholar]
  • 28. Straw B. Decrease in platelet count after vaccination with distemper‐hepatitis (DH) vaccine. Vet Med Small Anim Clin 1978; June:725–726. [PubMed] [Google Scholar]
  • 29. Axthelm MK, Krakowka S. Canine distemper virus‐induced thrombocytopenia. Am J Vet Res 1987;48:1269–1275. [PubMed] [Google Scholar]
  • 30. Olivares M., Walter T., Osorio M., et al. Anemia of a mild viral infection: The measles vaccine as a model. Pediatrics 1989; 84:851–855. [PubMed] [Google Scholar]
  • 31. Patterson R., Anderson J. Allergic reactions to drugs and biologic agents. J Am Med Assoc 1982;248:2637–2645. [PubMed] [Google Scholar]
  • 32. Fischlack M., Roubinian JR, Talal N. Lipopolysaccharide induction of IgM antibodies to polyadenylic acid in normal mice. J Immunol 1978;120:1856–1861. [PubMed] [Google Scholar]
  • 33. Atkinson JP. Factors that alter erythrocyte clearance patterns. Ann Intern Med 1977;87:213–217. [Google Scholar]
  • 34. Packman CH, Leddy JP. Acquired hemolytic anemia due to warm‐reacting autoantibodies In: Williams JW, Beutler E., Erslev AJ, et al, eds. Hematology, 4th ed. New York , NY : McGraw‐Hill; 1990:666–675. [Google Scholar]
  • 35. Smith CA. Current concepts: Are we vaccinating too much J Am Vet Med Assoc 1995;207:421–425. [PubMed] [Google Scholar]

Articles from Journal of Veterinary Internal Medicine are provided here courtesy of Wiley

RESOURCES